Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Controlled Trial of N-acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05122559
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:15.189077+00:00
Published At
2026-03-11T00:00:00+00:00
Record Updated At
2026-03-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Multiple Sclerosis", "Multiple Sclerosis, Primary Progressive", "Multiple Sclerosis, Secondary Progressive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-11"
protocolSection.identificationModule.nctId
"NCT05122559"
protocolSection.identificationModule.officialTitle
"Randomized Controlled Trial of N-acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Multiple Sclerosis (protocolSection.conditionsModule.conditions)
  • Multiple Sclerosis, Primary Progressive (protocolSection.conditionsModule.conditions)
  • Multiple Sclerosis, Secondary Progressive (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.